top of page
Search

BTS/SIGN Respiratory Updates for MRCP Part 1

TL;DR

The Guidelines: Recent BTS/SIGN Updates (Resp) are essential for MRCP Part 1, especially for asthma, COPD, pneumonia, oxygen therapy, and pleural disease. The exam focuses on applying UK guideline-based decisions, including oxygen targets, CURB-65 scoring, and treatment escalation. Prioritise understanding algorithms over memorising details. This approach significantly improves performance in single-best-answer questions.


Why this matters

Respiratory medicine is a core scoring domain in MRCP Part 1, and many questions are directly aligned with British Thoracic Society (BTS) and SIGN guidance. The exam tests whether you can apply standard UK clinical pathways rather than recall obscure facts.

A structured approach is key: begin with the MRCP Part 1 overview and reinforce your learning using Free MRCP MCQs.


Core sections

Scope of BTS/SIGN Respiratory Guidelines

The five most tested respiratory guideline areas are:

  1. Asthma diagnosis and stepwise management

  2. COPD diagnosis and treatment escalation

  3. Community-acquired pneumonia (CAP)

  4. Oxygen therapy and target saturation ranges

  5. Pleural disease (effusion and pneumothorax)

These represent the majority of respiratory guideline-based questions in MRCP Part 1.

1. Asthma: BTS/SIGN Updates

Modern BTS/SIGN guidance prioritises early anti-inflammatory therapy:

  • Diagnosis requires objective testing:

    • Spirometry with reversibility

    • FeNO (fractional exhaled nitric oxide)

  • Stepwise management:

    • Step 1: Low-dose ICS + SABA

    • Step 2: Regular ICS

    • Step 3: Add LABA

    • Step 4: Increase ICS dose ± LTRA

    • Step 5: Refer for biologic therapy

Exam insight: SABA-only treatment is outdated—this is a frequent exam trap.

2. COPD: Diagnosis and Management

  • Diagnosis requires:

    • Post-bronchodilator FEV1/FVC < 0.7

  • Treatment pathway:

    • Short-acting bronchodilators → LABA or LAMA

    • Persistent symptoms → LABA + LAMA

    • Frequent exacerbations → Triple therapy (ICS + LABA + LAMA)

  • Long-term oxygen therapy (LTOT):

    • PaO₂ ≤ 7.3 kPa

    • OR ≤ 8 kPa with complications (e.g., pulmonary hypertension)

3. Community-Acquired Pneumonia (CAP)

Severity is assessed using CURB-65:

Score

Interpretation

Management

0–1

Mild

Oral antibiotics (amoxicillin)

2

Moderate

Admit to hospital

≥3

Severe

Urgent admission ± ICU

Antibiotic strategy:

  • Mild → Amoxicillin

  • Moderate → Amoxicillin + clarithromycin

  • Severe → IV co-amoxiclav + macrolide

4. Oxygen Therapy (Very High Yield)

Correct oxygen prescription is frequently tested.

  • Target saturation:

    • 94–98% → Most patients

    • 88–92% → COPD / risk of hypercapnia

  • Delivery:

    • Use Venturi masks in COPD

Exam trap: High-flow oxygen in COPD can worsen CO₂ retention → respiratory acidosis.

5. Pleural Disease

Pneumothorax

  • Primary spontaneous:

    • <2 cm → Observe

    • 2 cm → Needle aspiration

  • Secondary pneumothorax:

    • More aggressive management required

Pleural Effusion

Use Light’s criteria:

  • Exudate → Infection, malignancy

  • Transudate → Heart failure, cirrhosis


10 High-Yield BTS/SIGN Exam Points

  1. ICS should be started early in asthma

  2. LABA must not be used without ICS

  3. CURB-65 guides pneumonia management

  4. COPD requires post-bronchodilator spirometry

  5. Oxygen targets differ in COPD vs others

  6. Venturi masks are preferred in COPD

  7. LTOT is based on arterial oxygen levels

  8. Triple therapy is used in severe COPD

  9. Pleural effusion classification uses Light’s criteria

  10. Macrolides are key in moderate–severe CAP


Practical examples / mini-cases

MCQ Example

A 65-year-old man with COPD presents with acute breathlessness. His oxygen saturation is 82% on room air. What is the most appropriate initial management?

A. High-flow oxygen via non-rebreather maskB. Venturi mask targeting 88–92%C. Nasal cannula at 6 L/minD. No oxygen

Answer: B. Venturi mask targeting 88–92%

Explanation: BTS oxygen guidelines recommend controlled oxygen therapy for COPD patients at risk of hypercapnia, targeting saturations of 88–92%.


Medical student revising respiratory guidelines for MRCP Part 1 exam

Common pitfalls (5 bullets)

  • Prescribing LABA without ICS in asthma

  • Using pre-bronchodilator spirometry for COPD diagnosis

  • Ignoring CURB-65 scoring in CAP

  • Giving uncontrolled oxygen in COPD

  • Misclassifying pleural effusions without Light’s criteria


FAQs

1. Are BTS/SIGN guidelines important for MRCP Part 1?

Yes. Many questions directly test guideline-based decision-making in common respiratory conditions.

2. Which topic is most commonly tested?

Asthma and COPD are the most frequent, followed by pneumonia and oxygen therapy.

3. Do I need to memorise drug doses?

No. Focus on treatment pathways and drug choices rather than exact doses.

4. Is oxygen therapy frequently tested?

Yes—target saturation ranges and delivery devices are very high yield.

5. How should I revise these guidelines?

Use question-based learning with Free MRCP MCQs and simulate exam conditions with a Start a mock test.


Ready to start?

To master respiratory guideline questions, integrate active recall into your revision. Start with the MRCP Part 1 overview, practise extensively with MCQs, and test yourself under exam conditions. For deeper conceptual clarity, supplement your preparation with structured teaching via https://www.crackmedicine.co.uk/lectures/.


Sources

 
 
 

Comments

bottom of page